CA2624781A1

CA2624781A1 - Nanobodies' et polypeptides diriges contre l'egfr et l'igf-1r

Nanobodies' et polypeptides diriges contre l'egfr et l'igf-1r Download PDF

Info

Publication number: CA2624781A1
Authority: CA; Canada
Prior art keywords: amino acid; seq; sequences; nanobody; nanobodies
Prior art date: 2005-10-11
Legal status : Abandoned

Application number

CA002624781A

Other languages

English (en)

Inventor

Toon Laeremans

Hans De Haard

Hendricus Renerus Jacobus Mattheus Hoogenboom

Current Assignee

Ablynx NV

Original Assignee

Individual

Priority date

2005-10-11

Filing date

2006-10-11

Publication date

2007-04-19

2006-10-11 Application filed by Individual filed Critical Individual

2007-04-19 Publication of CA2624781A1 publication Critical patent/CA2624781A1/fr

Status Abandoned legal-status Critical Current

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 399
229920001184 polypeptide Polymers 0.000 title claims abstract description 394
102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 394
108010003723 Single-Domain Antibodies Proteins 0.000 title claims abstract description 351
108060006698 EGF receptor Proteins 0.000 title abstract description 14
238000000034 method Methods 0.000 claims abstract description 110
150000007523 nucleic acids Chemical class 0.000 claims abstract description 72
102000039446 nucleic acids Human genes 0.000 claims abstract description 61
108020004707 nucleic acids Proteins 0.000 claims abstract description 61
239000000203 mixture Substances 0.000 claims abstract description 29
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 9
125000003275 alpha amino acid group Chemical group 0.000 claims description 595
238000006467 substitution reaction Methods 0.000 claims description 287
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 218
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 217
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 216
150000001413 amino acids Chemical class 0.000 claims description 200
230000027455 binding Effects 0.000 claims description 160
239000000427 antigen Substances 0.000 claims description 122
108091007433 antigens Proteins 0.000 claims description 122
102000036639 antigens Human genes 0.000 claims description 122
206010028980 Neoplasm Diseases 0.000 claims description 93
238000012217 deletion Methods 0.000 claims description 78
230000037430 deletion Effects 0.000 claims description 78
238000003780 insertion Methods 0.000 claims description 78
230000037431 insertion Effects 0.000 claims description 78
230000014509 gene expression Effects 0.000 claims description 76
239000012634 fragment Substances 0.000 claims description 64
108010047041 Complementarity Determining Regions Proteins 0.000 claims description 31
201000011510 cancer Diseases 0.000 claims description 28
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 27
230000001965 increasing effect Effects 0.000 claims description 20
238000011282 treatment Methods 0.000 claims description 20
239000003814 drug Substances 0.000 claims description 18
241000124008 Mammalia Species 0.000 claims description 16
239000000523 sample Substances 0.000 claims description 15
201000010099 disease Diseases 0.000 claims description 14
208000035475 disorder Diseases 0.000 claims description 13
238000002360 preparation method Methods 0.000 claims description 11
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 8
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 8
102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 claims description 8
101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 claims description 8
241000282832 Camelidae Species 0.000 claims description 7
102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 claims description 7
101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 claims description 7
238000002560 therapeutic procedure Methods 0.000 claims description 7
239000012472 biological sample Substances 0.000 claims description 6
238000003745 diagnosis Methods 0.000 claims description 6
230000003993 interaction Effects 0.000 claims description 6
230000002829 reductive effect Effects 0.000 claims description 6
230000002265 prevention Effects 0.000 claims description 5
238000002741 site-directed mutagenesis Methods 0.000 claims description 5
238000011123 anti-EGFR therapy Methods 0.000 claims description 4
238000003384 imaging method Methods 0.000 claims description 4
230000028993 immune response Effects 0.000 claims description 4
230000003053 immunization Effects 0.000 claims description 4
230000002018 overexpression Effects 0.000 claims description 4
238000012216 screening Methods 0.000 claims description 4
108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 3
201000004681 Psoriasis Diseases 0.000 claims description 3
230000004054 inflammatory process Effects 0.000 claims description 3
210000004072 lung Anatomy 0.000 claims description 3
210000003097 mucus Anatomy 0.000 claims description 3
238000002708 random mutagenesis Methods 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 2
239000012216 imaging agent Substances 0.000 claims description 2
230000002401 inhibitory effect Effects 0.000 claims description 2
238000002703 mutagenesis Methods 0.000 claims description 2
231100000350 mutagenesis Toxicity 0.000 claims description 2
238000011321 prophylaxis Methods 0.000 claims description 2
206010039073 rheumatoid arthritis Diseases 0.000 claims 2
230000009824 affinity maturation Effects 0.000 claims 1
102000005962 receptors Human genes 0.000 abstract description 28
108020003175 receptors Proteins 0.000 abstract description 28
230000001225 therapeutic effect Effects 0.000 abstract description 16
102000001301 EGF receptor Human genes 0.000 abstract description 13
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 8
230000000069 prophylactic effect Effects 0.000 abstract description 6
230000012010 growth Effects 0.000 abstract description 5
102000004877 Insulin Human genes 0.000 abstract description 4
108090001061 Insulin Proteins 0.000 abstract description 4
229940125396 insulin Drugs 0.000 abstract description 4
235000001014 amino acid Nutrition 0.000 description 376
229940024606 amino acid Drugs 0.000 description 168
125000000539 amino acid group Chemical group 0.000 description 164
102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 description 160
210000004027 cell Anatomy 0.000 description 155
108090000623 proteins and genes Proteins 0.000 description 126
101100112922 Candida albicans CDR3 gene Proteins 0.000 description 112
102000004169 proteins and genes Human genes 0.000 description 111
230000000670 limiting effect Effects 0.000 description 95
235000018102 proteins Nutrition 0.000 description 95
102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 description 92
101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 description 92
101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 description 84
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 70
241000282414 Homo sapiens Species 0.000 description 49
239000002773 nucleotide Substances 0.000 description 35
125000003729 nucleotide group Chemical group 0.000 description 35
230000000875 corresponding effect Effects 0.000 description 34
230000000890 antigenic effect Effects 0.000 description 33
238000004519 manufacturing process Methods 0.000 description 28
230000002068 genetic effect Effects 0.000 description 26
239000013598 vector Substances 0.000 description 23
229910052717 sulfur Inorganic materials 0.000 description 22
229910052698 phosphorus Inorganic materials 0.000 description 21
238000001727 in vivo Methods 0.000 description 20
108010021625 Immunoglobulin Fragments Proteins 0.000 description 18
102000008394 Immunoglobulin Fragments Human genes 0.000 description 18
229910052731 fluorine Inorganic materials 0.000 description 18
230000004048 modification Effects 0.000 description 18
238000012986 modification Methods 0.000 description 18
108091028043 Nucleic acid sequence Proteins 0.000 description 17
241000894007 species Species 0.000 description 17
210000001519 tissue Anatomy 0.000 description 16
230000001580 bacterial effect Effects 0.000 description 15
125000000524 functional group Chemical group 0.000 description 15
230000001976 improved effect Effects 0.000 description 15
229910052720 vanadium Inorganic materials 0.000 description 15
230000008901 benefit Effects 0.000 description 14
229910052727 yttrium Inorganic materials 0.000 description 14
102000008100 Human Serum Albumin Human genes 0.000 description 13
108091006905 Human Serum Albumin Proteins 0.000 description 13
102000004506 Blood Proteins Human genes 0.000 description 12
108010017384 Blood Proteins Proteins 0.000 description 12
101001057612 Homo sapiens Dual specificity protein phosphatase 5 Proteins 0.000 description 12
241001465754 Metazoa Species 0.000 description 12
238000003556 assay Methods 0.000 description 12
-1 derivatives Proteins 0.000 description 12
102000043381 human DUSP5 Human genes 0.000 description 12
239000003446 ligand Substances 0.000 description 12
229910052757 nitrogen Inorganic materials 0.000 description 12
230000001105 regulatory effect Effects 0.000 description 12
230000008685 targeting Effects 0.000 description 12
230000006870 function Effects 0.000 description 11
108020004414 DNA Proteins 0.000 description 10
241000588724 Escherichia coli Species 0.000 description 10
108060003951 Immunoglobulin Proteins 0.000 description 10
230000000694 effects Effects 0.000 description 10
230000013595 glycosylation Effects 0.000 description 10
238000006206 glycosylation reaction Methods 0.000 description 10
102000018358 immunoglobulin Human genes 0.000 description 10
210000004881 tumor cell Anatomy 0.000 description 10
102000025171 antigen binding proteins Human genes 0.000 description 9
108091000831 antigen binding proteins Proteins 0.000 description 9
238000010494 dissociation reaction Methods 0.000 description 9
230000005593 dissociations Effects 0.000 description 9
229940079593 drug Drugs 0.000 description 9
230000002349 favourable effect Effects 0.000 description 9
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
230000011664 signaling Effects 0.000 description 9
229910052721 tungsten Inorganic materials 0.000 description 9
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
150000001875 compounds Chemical class 0.000 description 8
229910052739 hydrogen Inorganic materials 0.000 description 8
210000004962 mammalian cell Anatomy 0.000 description 8
210000000056 organ Anatomy 0.000 description 8
229920001223 polyethylene glycol Polymers 0.000 description 8
238000011160 research Methods 0.000 description 8
239000000126 substance Substances 0.000 description 8
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 8
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 7
108700028369 Alleles Proteins 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
101800003838 Epidermal growth factor Proteins 0.000 description 7
102400001368 Epidermal growth factor Human genes 0.000 description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
230000008499 blood brain barrier function Effects 0.000 description 7
210000001218 blood-brain barrier Anatomy 0.000 description 7
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 7
238000011161 development Methods 0.000 description 7
230000018109 developmental process Effects 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
229940116977 epidermal growth factor Drugs 0.000 description 7
210000005260 human cell Anatomy 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
239000002609 medium Substances 0.000 description 7
125000006850 spacer group Chemical group 0.000 description 7
NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 6
206010006187 Breast cancer Diseases 0.000 description 6
208000026310 Breast neoplasm Diseases 0.000 description 6
241000196324 Embryophyta Species 0.000 description 6
101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 6
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 6
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
108010076504 Protein Sorting Signals Proteins 0.000 description 6
102400001320 Transforming growth factor alpha Human genes 0.000 description 6
101800004564 Transforming growth factor alpha Proteins 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
231100000433 cytotoxic Toxicity 0.000 description 6
230000001472 cytotoxic effect Effects 0.000 description 6
208000037765 diseases and disorders Diseases 0.000 description 6
239000012636 effector Substances 0.000 description 6
229940082789 erbitux Drugs 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
238000000855 fermentation Methods 0.000 description 6
230000004151 fermentation Effects 0.000 description 6
238000001415 gene therapy Methods 0.000 description 6
102000045108 human EGFR Human genes 0.000 description 6
210000003000 inclusion body Anatomy 0.000 description 6
230000003834 intracellular effect Effects 0.000 description 6
229910052751 metal Inorganic materials 0.000 description 6
239000002184 metal Substances 0.000 description 6
150000002739 metals Chemical class 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 5
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
101000693967 Trachemys scripta 67 kDa serum albumin Proteins 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000012790 confirmation Methods 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
230000004927 fusion Effects 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
230000006320 pegylation Effects 0.000 description 5
210000001322 periplasm Anatomy 0.000 description 5
230000004481 post-translational protein modification Effects 0.000 description 5
230000008569 process Effects 0.000 description 5
230000035755 proliferation Effects 0.000 description 5
230000028327 secretion Effects 0.000 description 5
108091026890 Coding region Proteins 0.000 description 4
108020004705 Codon Proteins 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
241000701024 Human betaherpesvirus 5 Species 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
102000035195 Peptidases Human genes 0.000 description 4
239000004365 Protease Substances 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
102000007562 Serum Albumin Human genes 0.000 description 4
108010071390 Serum Albumin Proteins 0.000 description 4
102000004338 Transferrin Human genes 0.000 description 4
108090000901 Transferrin Proteins 0.000 description 4
238000010171 animal model Methods 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
238000006471 dimerization reaction Methods 0.000 description 4
230000002538 fungal effect Effects 0.000 description 4
108020001507 fusion proteins Proteins 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
238000011065 in-situ storage Methods 0.000 description 4
239000003550 marker Substances 0.000 description 4
150000001457 metallic cations Chemical class 0.000 description 4
238000010647 peptide synthesis reaction Methods 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
238000012552 review Methods 0.000 description 4
230000009919 sequestration Effects 0.000 description 4
230000009870 specific binding Effects 0.000 description 4
231100000331 toxic Toxicity 0.000 description 4
230000002588 toxic effect Effects 0.000 description 4
230000001988 toxicity Effects 0.000 description 4
231100000419 toxicity Toxicity 0.000 description 4
239000012581 transferrin Substances 0.000 description 4
230000009466 transformation Effects 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
108010088751 Albumins Proteins 0.000 description 3
108090001008 Avidin Proteins 0.000 description 3
VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
101000874179 Homo sapiens Syndecan-1 Proteins 0.000 description 3
241000235058 Komagataella pastoris Species 0.000 description 3
241000235648 Pichia Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
102100035721 Syndecan-1 Human genes 0.000 description 3
108010048889 Thyroxine-Binding Proteins Proteins 0.000 description 3
102000009488 Thyroxine-Binding Proteins Human genes 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
230000004913 activation Effects 0.000 description 3
238000007792 addition Methods 0.000 description 3
230000000259 anti-tumor effect Effects 0.000 description 3
230000004888 barrier function Effects 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000002648 combination therapy Methods 0.000 description 3
JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 3
230000009260 cross reactivity Effects 0.000 description 3
239000013078 crystal Substances 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
239000000824 cytostatic agent Substances 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000003828 downregulation Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
238000009472 formulation Methods 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
230000005847 immunogenicity Effects 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
230000010354 integration Effects 0.000 description 3
230000035800 maturation Effects 0.000 description 3
229940127285 new chemical entity Drugs 0.000 description 3
229960001972 panitumumab Drugs 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
230000003248 secreting effect Effects 0.000 description 3
239000007858 starting material Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
230000009261 transgenic effect Effects 0.000 description 3
210000005253 yeast cell Anatomy 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 2
BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 2
101710187573 Alcohol dehydrogenase 2 Proteins 0.000 description 2
101710133776 Alcohol dehydrogenase class-3 Proteins 0.000 description 2
244000303258 Annona diversifolia Species 0.000 description 2
235000002198 Annona diversifolia Nutrition 0.000 description 2
101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 2
241000282836 Camelus dromedarius Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
241000701489 Cauliflower mosaic virus Species 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102000009109 Fc receptors Human genes 0.000 description 2
108010087819 Fc receptors Proteins 0.000 description 2
102000009465 Growth Factor Receptors Human genes 0.000 description 2
108010009202 Growth Factor Receptors Proteins 0.000 description 2
108010006464 Hemolysin Proteins Proteins 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 2
108010031794 IGF Type 1 Receptor Proteins 0.000 description 2
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
206010023849 Laryngeal papilloma Diseases 0.000 description 2
206010027476 Metastases Diseases 0.000 description 2
208000034578 Multiple myelomas Diseases 0.000 description 2
108010085220 Multiprotein Complexes Proteins 0.000 description 2
102000007474 Multiprotein Complexes Human genes 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
244000061176 Nicotiana tabacum Species 0.000 description 2
235000002637 Nicotiana tabacum Nutrition 0.000 description 2
206010033128 Ovarian cancer Diseases 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241001494479 Pecora Species 0.000 description 2
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
101000693961 Trachemys scripta 68 kDa serum albumin Proteins 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000013543 active substance Substances 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
210000002806 clathrin-coated vesicle Anatomy 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
210000000172 cytosol Anatomy 0.000 description 2
230000001085 cytostatic effect Effects 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
201000010536 head and neck cancer Diseases 0.000 description 2
208000014829 head and neck neoplasm Diseases 0.000 description 2
239000003228 hemolysin Substances 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
230000002998 immunogenetic effect Effects 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
238000002372 labelling Methods 0.000 description 2
201000000089 larynx squamous papilloma Diseases 0.000 description 2
108020001756 ligand binding domains Proteins 0.000 description 2
229920001427 mPEG Polymers 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
229950008001 matuzumab Drugs 0.000 description 2
230000010534 mechanism of action Effects 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
230000035772 mutation Effects 0.000 description 2
230000009826 neoplastic cell growth Effects 0.000 description 2
238000001668 nucleic acid synthesis Methods 0.000 description 2
210000003463 organelle Anatomy 0.000 description 2
230000035515 penetration Effects 0.000 description 2
229960003330 pentetic acid Drugs 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
238000010837 poor prognosis Methods 0.000 description 2
230000007017 scission Effects 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
230000004614 tumor growth Effects 0.000 description 2
239000000439 tumor marker Substances 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
241000589158 Agrobacterium Species 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
101710187578 Alcohol dehydrogenase 1 Proteins 0.000 description 1
102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
108010025188 Alcohol oxidase Proteins 0.000 description 1
102100036826 Aldehyde oxidase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
102100028449 Arginine-glutamic acid dipeptide repeats protein Human genes 0.000 description 1
241001523626 Arxula Species 0.000 description 1
108010024976 Asparaginase Proteins 0.000 description 1
102000015790 Asparaginase Human genes 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241000228212 Aspergillus Species 0.000 description 1
241000228245 Aspergillus niger Species 0.000 description 1
241000131386 Aspergillus sojae Species 0.000 description 1
102100028169 BET1-like protein Human genes 0.000 description 1
101710138653 BET1-like protein Proteins 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
241000680806 Blastobotrys adeninivorans Species 0.000 description 1
241000255789 Bombyx mori Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000193764 Brevibacillus brevis Species 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
101100327917 Caenorhabditis elegans chup-1 gene Proteins 0.000 description 1
101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
108091006146 Channels Proteins 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
102000005853 Clathrin Human genes 0.000 description 1
108010019874 Clathrin Proteins 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
102000000989 Complement System Proteins Human genes 0.000 description 1
108010069112 Complement System Proteins Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102100030497 Cytochrome c Human genes 0.000 description 1
108010075031 Cytochromes c Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
101150039808 Egfr gene Proteins 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
102100023328 G-protein coupled estrogen receptor 1 Human genes 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
102100022624 Glucoamylase Human genes 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
101001061654 Homo sapiens Arginine-glutamic acid dipeptide repeats protein Proteins 0.000 description 1
101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
101000829902 Homo sapiens G-protein coupled estrogen receptor 1 Proteins 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
241000235649 Kluyveromyces Species 0.000 description 1
241001138401 Kluyveromyces lactis Species 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
241000194036 Lactococcus Species 0.000 description 1
235000019687 Lamb Nutrition 0.000 description 1
241000255777 Lepidoptera Species 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
240000004658 Medicago sativa Species 0.000 description 1
235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010059724 Micrococcal Nuclease Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101000930477 Mus musculus Albumin Proteins 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
241000221961 Neurospora crassa Species 0.000 description 1
230000004989 O-glycosylation Effects 0.000 description 1
108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
241000320412 Ogataea angusta Species 0.000 description 1
241001452677 Ogataea methanolica Species 0.000 description 1
108700028353 OmpC Proteins 0.000 description 1
108700006385 OmpF Proteins 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
101150012394 PHO5 gene Proteins 0.000 description 1
102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
241000282577 Pan troglodytes Species 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108010053210 Phycocyanin Proteins 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
241000288906 Primates Species 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
241000588770 Proteus mirabilis Species 0.000 description 1
241000125945 Protoparvovirus Species 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
241000589540 Pseudomonas fluorescens Species 0.000 description 1
102000013009 Pyruvate Kinase Human genes 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
206010038389 Renal cancer Diseases 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010039491 Ricin Proteins 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000235346 Schizosaccharomyces Species 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
206010041067 Small cell lung cancer Diseases 0.000 description 1
241000221948 Sordaria Species 0.000 description 1
241000221950 Sordaria macrospora Species 0.000 description 1
241000256248 Spodoptera Species 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000191965 Staphylococcus carnosus Species 0.000 description 1
101000777492 Stichodactyla helianthus DELTA-stichotoxin-She4b Proteins 0.000 description 1
244000057717 Streptococcus lactis Species 0.000 description 1
235000014897 Streptococcus lactis Nutrition 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
241000187398 Streptomyces lividans Species 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
240000007591 Tilia tomentosa Species 0.000 description 1
241000723873 Tobacco mosaic virus Species 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
241000223259 Trichoderma Species 0.000 description 1
241000499912 Trichoderma reesei Species 0.000 description 1
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
241000235013 Yarrowia Species 0.000 description 1
241000235015 Yarrowia lipolytica Species 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
108091005764 adaptor proteins Proteins 0.000 description 1
102000035181 adaptor proteins Human genes 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
108010004469 allophycocyanin Proteins 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940125644 antibody drug Drugs 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000011681 asexual reproduction Effects 0.000 description 1
238000013465 asexual reproduction Methods 0.000 description 1
229960003272 asparaginase Drugs 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
244000309464 bull Species 0.000 description 1
HXCHCVDVKSCDHU-LULTVBGHSA-N calicheamicin Chemical compound C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-LULTVBGHSA-N 0.000 description 1
229930195731 calicheamicin Natural products 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
239000012830 cancer therapeutic Substances 0.000 description 1
238000000423 cell based assay Methods 0.000 description 1
230000034303 cell budding Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229960005395 cetuximab Drugs 0.000 description 1
239000013522 chelant Substances 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229930193282 clathrin Natural products 0.000 description 1
230000006395 clathrin-mediated endocytosis Effects 0.000 description 1
230000035071 co-translational protein modification Effects 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
108010066540 copper thionein Proteins 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000034994 death Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000011143 downstream manufacturing Methods 0.000 description 1
230000007783 downstream signaling Effects 0.000 description 1
238000009509 drug development Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
230000008482 dysregulation Effects 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
210000001339 epidermal cell Anatomy 0.000 description 1
108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000008713 feedback mechanism Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
102000034287 fluorescent proteins Human genes 0.000 description 1
108091006047 fluorescent proteins Proteins 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
230000004545 gene duplication Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical group OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000003128 head Anatomy 0.000 description 1
229940022353 herceptin Drugs 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
238000005734 heterodimerization reaction Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
229940116978 human epidermal growth factor Drugs 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
239000001573 invertase Substances 0.000 description 1
235000011073 invertase Nutrition 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
229940019452 loris Drugs 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
244000005700 microbiome Species 0.000 description 1
210000002500 microbody Anatomy 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
230000006654 negative regulation of apoptotic process Effects 0.000 description 1
GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
239000002547 new drug Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
108010054442 polyalanine Proteins 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
238000011533 pre-incubation Methods 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000000164 protein isolation Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000005180 public health Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
230000008060 renal absorption Effects 0.000 description 1
201000010174 renal carcinoma Diseases 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
231100000004 severe toxicity Toxicity 0.000 description 1
230000014639 sexual reproduction Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
229940126586 small molecule drug Drugs 0.000 description 1
239000000243 solution Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
230000005751 tumor progression Effects 0.000 description 1
108010087967 type I signal peptidase Proteins 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
229960004355 vindesine Drugs 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1